Lasers for Psoriasis and Hypopigmentation



One of the most recent advancements in phototherapy is the development of localized delivery systems. One such device is the excimer laser. The use of the excimer laser was first reported in dermatology by Bonis in 1997 for psoriasis treatment.1 Psoriasis has been reported to respond best to light at a wavelength of 313 nm.2 Since the excimer laser emits light at a wavelength of 308 nm, it was a logical choice for investigation. The excimer laser has been found to be efficacious for not only patients suffering from psoriasis but also several disorders of hypopigmentation including vitiligo. This chapter serves to discuss the use of the excimer laser for psoriasis and diseases of hypopigmentation.


Excimer Laser Skin Type Light Therapy Psoriatic Lesion Vitiligo Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1.  1.
    Bónis B, Kemény L, Dobozy A, Bor Z, Szabó G, Ignácz F. 308 nm UVB excimer laser for psoriasis. Lancet. 1997;350:1522.PubMedCrossRefGoogle Scholar
  2.  2.
    Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 1981;76:359-362.PubMedCrossRefGoogle Scholar
  3.  3.
    Spencer JM, Hadi SM. The excimer lasers. J Drugs Dermatol. 2004;3:522-525.PubMedGoogle Scholar
  4.  4.
    Kemény L, Bónis B, Dobozy A, Bor Z, Szabó G, Ignácz F. 308-nm excimer laser therapy for psoriasis. Arch Dermatol. 2001;137:95-96.PubMedGoogle Scholar
  5.  5.
    Feldman SR, Mellen BG, Housman TS, Fitzpatrick RE, Geronemus RG, et al. Efficacy of the 308 nm excimer laser for treatment of psoriasis: results of a multicenter study. J Am Acad Dermatol. 2002;46:900-906.PubMedCrossRefGoogle Scholar
  6. 6.
    Erceg A, Bovenschen HJ, van de Kerkhof PC, Seyger MM. Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: a comparative study. Br J Dermatol. 2006;155:110-114.PubMedCrossRefGoogle Scholar
  7.  7.
    Ilknur T, Akarsu S, Aktan S, Ozkan S. Comparison of the effects of pulsed dye laser, pulsed dye laser  +  salicylic acid, and clobetasole propionate  +  salicylic acid on psoriatic plaques. Dermatol Surg. 2006;32:49-55.PubMedCrossRefGoogle Scholar
  8.  8.
    Bovenschen HJ, Erceg A, Van Vlijmen-Willems I, Van De Kerkhof PC, Seyger MM. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization. J Dermatol Treat. 2007;18:32-39.CrossRefGoogle Scholar
  9.  9.
    Hadi S, Tinio P, Al-Ghaithi K, et al. Treatment of vitiligo using the 308-nm excimer laser. Photomed Laser Surg. 2006;24:354-357.PubMedCrossRefGoogle Scholar
  10. 10.
    Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg. 2004;30:130-135.PubMedCrossRefGoogle Scholar
  11. 11.
    Thomas C. Taber’s Cyclopedic Medical Dictionary. 17th ed. Philadelphia: F.A. Davis Co; 1993:1102.Google Scholar
  12. 12.
    Friedman PM, Geronemus RG. Use of the 308-nm excimer laser for post resurfacing leukoderma. Arch Dermatol. 2001;137:824-825.PubMedGoogle Scholar
  13. 13.
    Alexiades-Armenakas MR, Bernstein LJ, Friedman PM, Geronemus RG. The safety and efficacy of the 308-nm excimer laser for pigment correction of hypopigmented scars and striae alba. Arch Dermatol. 2004;140:955-960.PubMedCrossRefGoogle Scholar
  14. 14.
    Goldberg DJ, Sarradet D, Hussain M. 308-nm excimer laser treatment of mature hypopigmented striae. Dermatol Surg. 2003;29:596-599.PubMedCrossRefGoogle Scholar
  15. 15.
    Ortonne JP, Passeron T. Melanin pigmentary disorders: treatment update. Dermatol Clin. 2005;23:209-226.PubMedCrossRefGoogle Scholar
  16. 16.
    Asawanonda P, Anderson RR, Chang Y, Taylor CR. 308 nm excimer laser for the treatment of psoriasis: a dose-response study. Arch Dermatol. 2000;136:619-624.PubMedCrossRefGoogle Scholar
  17. 17.
    National Psoriasis Foundation, Research pipeline: drugs in development,

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  1. 1.Center for Surgical DermatologyWestervilleUSA
  2. 2.Spencer Dermatology & Skin SurgerySt. PetersburghUSA

Personalised recommendations